ResearchSafe

FDA cracking down on compounded GLP-1s, what happens to access?

Posted by experiment705 in Weight Loss & Metabolic - 2 points, 4 comments.

https://www.scientificamerican.com/article/why-the-fda-is-cracking-down-on-compound-glp-1-drugs-for-weight-loss

Scientific American has a piece on the FDA moving to restrict mass-market compounded GLP-1 drugs, basically targeting questionable active ingredients and misleading ads while the branded supply stabilises. Worth a read if you are tracking where this whole compounding situation is heading.

I have mixed feelings about this. On one hand, some of these med spa operations were clearly cutting corners and the quality control was basically nonexistent in some cases. I have seen people get wildly inconsistent results from compounded semaglutide, and when you actually look at the data people share, the response curves are all over the place compared to branded. But on the other hand, the FDA pulling access too fast could just push people toward grey market sources that are even worse. The article does not really dig into what happens to the people who genuinely cannot afford branded versions.

Anyone here switched from compounded to branded recently, or the other way? Would be curious to hear if you noticed a real difference in appetite suppression or side effects.

Comments

  • fasted_scientist: I reckon the grey market point is the one nobody wants to deal with. Restrict compounding and you don't eliminate demand, you just shift it somewhere with even less oversight. Seen that pattern plenty of times with other stuff. The inconsistent results thing is fair but I'd want to see actual data on it rather than forum anecdotes (and I say that as someone who usually finds anecdotes useful for generating questions). Were people dosing properly? Were they storing it wrong? Half the "compounded
  • experiment705: Yeah the grey market shift is basically the obvious consequence nobody in charge wants to say out loud. You restrict supply but demand stays the same, people find a way. On the inconsistent results, fair point about user error. But I tracked my own response pretty carefully, HRV and weight trends and appetite logs, and I was pretty meticulous about storage and reconstitution. Still saw noticeably flatter appetite suppression with compounded compared to what I expected from the research on brand
  • medic_frugal: Thats a fair point on the grey market shift, ive seen that exact pattern play out with other compounds and its never pretty. And youre right that user error probably accounts for a chunk of the inconsistency stories, but ive also seen enough people who seemed pretty careful with storage and dosing still getting weird results, so im not sure its all explained away by that. Would love to see some actual analytical testing data on compounded semaglutide potency versus label claim but i dont think t
  • experiment705: Yeah that is exactly what worries me, the careful users who still got weird results. I tracked my own response pretty closely when I was on compounded semaglutide and my hunger suppression was basically unpredictable week to week despite keeping everything cold and dosing consistently. Could have been plenty of factors but it felt off. And you are right about the testing data, nobody is going to volunteer that. Maybe an independent lab could do a blind batch test if enough people chipped in, bu

Community discussion - research and educational context only. Not medical advice.